Cargando…
Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes
AIM: Our aim was to investigate the effects of add-on canagliflozin with glimepiride dose adjustment or glimepiride dose adjustment on pancreatic beta cell function in patients with type 2 diabetes mellitus and inadequate glycemic control despite stable triple therapy (metformin, teneligliptin, and...
Autores principales: | Takahara, Mitsuyoshi, Shiraiwa, Toshihiko, Matsuoka, Taka-aki, Yamamoto, Kaoru, Maeno, Yoshifumi, Shiraiwa, Yuka, Yoshida, Yoko, Katakami, Naoto, Iijima, Hiroaki, Katsumata, Hideyuki, Arakawa, Kenji, Hashimoto, Toshio, Shimomura, Iichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683829/ https://www.ncbi.nlm.nih.gov/pubmed/33244248 http://dx.doi.org/10.2147/DMSO.S273396 |
Ejemplares similares
-
Screening for a Decreased Masticatory Function by a Color-changeable Chewing Gum Test in Patients with Metabolic Disease
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022) -
Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022) -
Lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the coronavirus disease 2019 pandemic in Japan
por: Takahara, Mitsuyoshi, et al.
Publicado: (2021) -
Efficacy of liraglutide therapy in Japanese type 2 diabetic patients insufficiently controlled with basal‐supported oral therapy
por: Takahara, Mitsuyoshi, et al.
Publicado: (2012) -
Patient Perspectives on Combination Therapy of a Once-weekly Oral Medication Plus Daily Medication for Lifestyle-related Chronic Diseases
por: Takahara, Mitsuyoshi, et al.
Publicado: (2017)